Wang Qiang, Kesen Savas, Liljeroth Maria, Nilsson Henrik, Zhao Ying, Sparrelid Ernesto, Brismar Torkel B
Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Department of Radiology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Scand J Gastroenterol. 2022 Jun;57(6):705-712. doi: 10.1080/00365521.2022.2032321. Epub 2022 Feb 2.
Three types of gadoxetic acid enhanced MRI parameters have been proposed to quantify liver function. However, until now there is no consensus on which one that has the greatest potential for use in clinical practice. This study was conducted to compare the efficacy of three types of gadoxetic acid enhanced MR parameters for quantitative assessment of liver function.
Imaging data of 10 patients with chronic liver disease and 20 healthy volunteers were analyzed. Parameters based on signal intensity(SI), T1 changes or dynamic-hepatocyte-specific-contrast-enhancement MR were calculated. Their mutual correlations, discriminatory capacity between cirrhotic and healthy liver and correlations with Child-Pugh score and Model for end-stage liver-disease (MELD) were estimated.
The strongest correlations were observed between relative enhancement of the liver and T1 time at 20 min after contrast agent injection, and between liver-spleen contrast ratio at 20 min after contrast agent injection and hepatic uptake rate (|r|> 0.90, < .05, both). All parameters but input-relative blood flow ( = 0.17) were significantly different between patient and control group ( < .05), with AUROCs of liver-to-muscle ratio (LMR), increase of LMR and hepatic extraction fraction greater than 0.90 ( < .05). Liver-to-spleen ratio, LMR and hepatic uptake index presented a strong correlation with Child-Pugh score and MELD (|r|> 0.8, < .05).
Simple SI-based parameters were as good as more complex parameters in evaluating liver function at gadoxetic acid enhanced MR. In clinical routine LMR seems to be the easiest-to-use parameter for quantitative evaluation of liver function.
已提出三种钆塞酸增强磁共振成像(MRI)参数来量化肝功能。然而,迄今为止,对于哪一种参数在临床实践中具有最大应用潜力尚无共识。本研究旨在比较三种钆塞酸增强磁共振参数在定量评估肝功能方面的效果。
分析了10例慢性肝病患者和20名健康志愿者的影像数据。计算基于信号强度(SI)、T1变化或动态肝细胞特异性对比增强磁共振的参数。评估它们之间的相互相关性、肝硬化肝脏与健康肝脏之间的鉴别能力以及与Child-Pugh评分和终末期肝病模型(MELD)的相关性。
在注射造影剂后20分钟时,肝脏相对增强与T1时间之间,以及注射造影剂后20分钟时肝脏-脾脏对比率与肝脏摄取率之间观察到最强的相关性(|r|>0.90,P<0.05)。除输入相对血流量(P=0.17)外,所有参数在患者组和对照组之间均有显著差异(P<0.05),肝-肌比(LMR)、LMR增加和肝提取分数的受试者工作特征曲线下面积(AUROC)大于0.90(P<0.05)。肝脾比、LMR和肝脏摄取指数与Child-Pugh评分和MELD呈强相关(|r|>0.8,P<0.05)。
在钆塞酸增强磁共振成像评估肝功能方面,基于简单信号强度的参数与更复杂的参数效果相当。在临床常规检查中,LMR似乎是用于定量评估肝功能的最易于使用的参数。